“●휴게텔추천●《 YEOTOP6 。 COM 》 소사동오피ⅴ소사동립카페✣소사동오피✘소사동키스방✣소사동출장✄소사동건마や소사동스파”的搜索结果，显示 151-160 项，共有 16572 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objectives for this study are: The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (5) advanced, unresectable colorectal cancer, (6) advanced, unresectable ovarian cancer, (7) advanced, unresectable clear cell kidney cancer, (8) advanced ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (5) advanced, unresectable colorectal cancer, (6) advanced, unresectable ovarian cancer, (7) advanced, unresectable clear cell kidney cancer, (8) advanced ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (5) advanced, unresectable colorectal cancer, (6) advanced, unresectable ovarian cancer, (7) advanced, unresectable clear cell kidney cancer, (8) advanced ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... (5) advanced, unresectable colorectal cancer, (6) advanced, unresectable ovarian cancer, (7) advanced, unresectable clear cell kidney cancer, (8) advanced ...